325775-44-8

Basic information

• Product Name: 1-Boc-3-(Aminomethyl)azetidine
• Synonyms: TERT-BUTYL 3-(AMINOMETHYL)AZETIDINE-1-CARBOXYLATE;1-N-BOC-3-AMINOMETHYL AZETIDINE;1-BOC-3-(AMINOMETHYL)AZETIDINE;3-AMINOMETHYL-1-N-BOC-AZETIDINE;3-AMINOMETHYL-AZETIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER;1-BOC-3-AMINOMETHYLAZETIDINE,98+%;1-Boc-aminoazetidine;1-Boc-3-Aminomethylazetidine HCl
• CAS NO: 325775-44-8
• Molecular Formula: C₉H₁₈N₂O₂
• Molecular Weight: 186.25
• Product Categories: pharmacetical;Aminomethyl's;Azetidine;Ring Systems
• Mol File: 325775-44-8.mol
• Article Data: 2

Chemical Properties

• Boiling Point: 260.583 °C at 760 mmHg
• Flash Point: >110 °C
• Appearance: /
• Density: 1.0234 g/mL at 25 °C
• Vapor Pressure: 0.012mmHg at 25°C
• Refractive Index: 1.4670
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• PKA: 9.97±0.29(Predicted)
• Sensitive: Air Sensitive
• CAS DataBase Reference: 1-Boc-3-(Aminomethyl)azetidine(CAS DataBase Reference)
• NIST Chemistry Reference: 1-Boc-3-(Aminomethyl)azetidine(325775-44-8)
• EPA Substance Registry System: 1-Boc-3-(Aminomethyl)azetidine(325775-44-8)

Safety Data

• Hazard Codes: C,T
• Statements: 36/37/38-25
• Safety Statements: 26-36/37/39-45
• RIDADR: 2810
• WGK Germany: 1
• HazardClass: IRRITANT
• PackingGroup: Ⅲ
• Hazardous Substances Data: 325775-44-8(Hazardous Substances Data)

Usage

General Description

1-Boc-3-(Aminomethyl)azetidine is a chemical compound with the formula C9H17NO2. It is a derivative of azetidine, a four-membered nitrogen-containing ring. The "Boc" in its name refers to the tert-butyloxycarbonyl protecting group, which is commonly used in organic synthesis to protect amines and other reactive functional groups. The compound contains an aminomethyl group attached to the azetidine ring, making it potentially useful in the synthesis of pharmaceuticals and other organic molecules. The presence of the Boc group also makes it more stable and easier to handle in laboratory settings.

InChI:InChI=1/C9H18N2O2/c1-9(2,3)13-8(12)11-5-7(4-10)6-11/h7H,4-6,10H2,1-3H3

Upstream product

• 141699-58-3 3-methanesulfonyloxy-azetidine-1-carboxylic acid tert-butyl ester 
• 141699-55-0 tert-butyl 3-hydroxyazetidine-1-carboxylate 
• 142253-54-1 tert-butyl 3-cyanoazetidine-1-carboxylate 

Downstream Products

• 1028286-25-0 3-(benzoylamino-methyl)-azetidine-1-carboxylic acid tert-butyl ester 
• 1026942-02-8 3-(benzenesulfonylamino-methyl)-azetidine-1-carboxylic acid tert-butyl ester 
• 1026576-25-9 3-[(cyclohexanecarbonyl-amino)-methyl]-azetidine-1-carboxylic acid tert-butyl ester 
• 876149-42-7 1,1-dimethylethyl 3-[({[(phenylmethyl)oxy]carbonyl}amino)methyl]-1-azetidinecarboxylate 
• 1201691-78-2 3-{[4-(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b][1,4]diazepin-2-ylamino)-3-methoxy-benzoylamino]-methyl}-azetidine-1-carboxylic acid tert-butyl ester 
• 1265774-80-8 tert-butyl 3-{[1-(tert-butoxycarbonyl)azetidin-3-yl]methyl}-5-(3-fluoro-4-methoxybenzyl)-2-methyl-2,3-dihydropyrrolo[3',2':5,6]pyrido[3,4-b]indole-6(1H)-carboxylate 
• 1366767-94-3 1,1-dimethylethyl 3-{[3-(4-bromo-2-fluorophenyl)-4H-1,2,4-triazol-4-yl]methyl}-1-azetidinecarboxylate 
• 1366767-46-5 6-[4-(4-{[1-(cyclopropylcarbonyl)-3-azetidinyl]methyl}-4H-1,2,4-triazol-3-yl)-3-fluorophenyl]-1H-indole 
• 1366767-95-4 3-(4-bromo-2-fluorophenyl)-4-{[1-(cyclopropylcarbonyl)-3-azetidinyl]methyl}-4H-1,2,4-triazole 
• 1366767-57-8 6-[4-(4-{[1-(cyclopropylcarbonyl)-3-azetidinyl]methyl}-4H-1,2,4-triazol-3-yl)-3-fluorophenyl] quinoline 
• 1366767-62-5 7-[4-(4-{[1-(cyclopropylcarbonyl)-3-azetidinyl]methyl}-4H-1,2,4-triazol-3-yl)-3-fluorophenyl]quinoline 
• 1366767-92-1 1,1-dimethylethyl 3-{[3-(4-bromophenyl)-4H-1,2,4-triazol-4-yl]methyl}-1-azetidinecarboxylate 
• 1173206-71-7 1-Boc-3-(aminomethyl)azetidine hydrochloride 
• 1575820-10-8 tert-butyl 3-[[(2-nitrophenyl)amino]methyl]-azetidine-1-carboxylate 

Relevant articles and documents

Cathepsin cysteine protease inhibitors

This invention relates to a novel class of compounds which are cysteine protease inhibitors, including but not limited to, inhibitors of Cathepsins K and L. These compounds are useful for treating diseases in which inhibition of bone resorption is indicated, such as osteoporosis.